Monday, 28th February is #RareDiseaseDay
We are proud to work with amazing companies focused on developing new treatments for rare diseases, generating change for the 300 million people worldwide
AMSilk’s certified-vegan, silk-like BioSteel fibre, is used by Mercedes-Benz for its VISION EQXX.
In January, AMSilk, a world leader in supplying innovative high-performance bio-based silk materials, entered into a collaboration with Mercedes-Benz for its VISION EQXX, its latest electric vehicle concept, a key step in ensuring a greener planet. AMSilk’s certified-vegan, silk-like BioSteel fibre, is used for the innovative door pulls. The use of a biotechnology-based and certified-vegan […]
Novo Seeds – Building Exceptional Companies for Global Impact
2021 was an outstanding year for Novo Seeds in terms of venture creation. Novo Seeds’ commitment to early-stage financing and venture creation resulted in an unprecedented amount of capital and interest from fellow VCs across Europe and the US in 2021, with over US$550 million raised by Novo Seeds’ portfolio companies. Focused on maximising the […]
Sachs Associates Healthcare Events 2022
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
Scrip Award Nominees 2021
The Optimum Team are looking forward to the Scrip Awards on Thursday 2nd December, always a fantastic event and great to see clients nominated for their amazing work; Verona Pharma for Financing Deal of the Year, Artios Pharma for Best Partnership Alliance together with Merck KGaA and Calliditas Therapeutics for both Biotech Company of the Year and Clinical Advance of the Year for its Phase […]
